Real-World Analysis of the Efficacy and Safety of a Novel Irreversible HER2 Tyrosine Kinase Inhibitor Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer

Real-World Analysis of the Efficacy and Safety of a Novel Irreversible HER2 Tyrosine Kinase Inhibitor Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer

Ying Sun,1,2,* Beibei Chen,3,4,* Jisheng Li,3,* Ling Peng,5 Shuguang Li,3 Xuejun Yu,3 Li Li3 1Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Basic Medical Science, Cheeloo College of Medicine, Shandong University...

Full description

Bibliographic Details
Main Authors: Sun Y, Chen B, Li J, Peng L, Li S, Yu X, Li L
Format: Article
Language:English
Published: Dove Medical Press 2021-09-01
Series:Cancer Management and Research
Subjects:
breast cancer
her2 positive
pyrotinib
adverse effect
objective response rate
Online Access:https://www.dovepress.com/real-world-analysis-of-the-efficacy-and-safety-of-a-novel-irreversible-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/real-world-analysis-of-the-efficacy-and-safety-of-a-novel-irreversible-peer-reviewed-fulltext-article-CMAR

Similar Items